@grandslam... A minor addition to your point. They filed a follow-up Form D that shows the complete filing is for $3 million, not $2 million. The $2 million is in place, and I guess they are looking to fill the other million. To me, this is likely Musick and the board telling the newer management team "time's up, we need to move forward with one of the clinical trials". Perhaps the idea is to start one of them, generate some media around it, and use that exposure to perhaps complete the IPO. Whatever the case, per your point, a company doesn't attract $3 million in capital if it is planning to shut down. I do have to wonder if this is foreign investment though, perhaps from China or elsewhere in the Far East.
